Stockscreener 앱 받기
21.55
0.33%
0.07
시간 외 거래:
21.55
Genmab Adr 주식(GMAB)의 최신 뉴스
Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL) - GlobeNewswire Inc.
Investing in Take-Two Interactive Software, Inc (TTWO) Is Getting More Attractive - knoxdaily.com
Investing in Genmab ADR (GMAB): What You Must Know - knoxdaily.com
Nucor Corp (NUE) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
EWTX Stock Sees Surge of Approximately 4.24% in Last Five Days - knoxdaily.com
GMAB or RGEN: Which Is the Better Value Stock Right Now? - Yahoo Finance
Should Value Investors Buy Genmab (GMAB) Stock? - Yahoo Finance
Genmab ADR (NASDAQ: GMAB) Jumps 1.19% In Recent Session. Here’s Everything You Need To Know. - Stocksregister
AGCO Corp (AGCO) Beta Value: Understanding the Market Risk - News Heater
Evercore Inc’s Mixed Bag: Down -29.24% in 6 Months, Down -20.22% in 30 Days - investchronicle.com
GMAB’s Debt-to-Equity Ratio at 0.03: What It Means for Genmab ADR’s Future - investchronicle.com
CZR Stock Sees Decline of Approximately -4.82% in Last Five Days - knoxdaily.com
Magnite Inc (MGNI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
DLocal Limited (DLO) Shares Decline Despite Market Challenges - The News Heater
Genmab ADR Inc. (GMAB) Price Performance: The Role of Supply and Demand - The InvestChronicle
Views of Wall Street’s Leading Experts on Genmab ADR - SETE News
What is Core & Main Inc (CNM) Stock Return on Shareholders’ Capital? - SETE News
There is no doubt that Kite Realty Group Trust (KRG) ticks all the boxes. - SETE News
Sea Ltd ADR (NYSE: SE) Jumps 4.64%, Turning Investors Away - Stocks Register
Does Genmab ADR (NASDAQ: GMAB) Still Look Hot This Week? - Stocks Register
Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - MSN
GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN
Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance
Genmab stock holds Buy rating on positive trial results - Investing.com
10 Biggest Biotechnology Companies - Investopedia
Weekly Upgrades and Downgrades - InvestorPlace
Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance
Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance
Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance
BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls - Yahoo Finance
RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance
Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily
GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews
Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch
Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily
GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada
New Strong Buy Stocks for January 11th - Yahoo Finance
Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Oncolytics Biotech Inc. (ONCY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Genmab AS Sponsored ADR (GMAB) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
INCY vs. GMAB: Which Stock Is the Better Value Option? - Yahoo Finance
Should You Buy Genmab (GMAB) Ahead of Earnings? - Yahoo Finance
Inside Genmab's blockbuster IPO - IR Magazine
0.39%
3.66%
자본화:
|
볼륨(24시간):